The hyperglycosylation of HIV envelope: An opportunity to alter virus infectivity?

被引:6
作者
Fenouillet, E [1 ]
Jones, IM [1 ]
机构
[1] NERC,INST VIROL,OXFORD OX1 3SR,ENGLAND
关键词
D O I
10.1007/BF02174015
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Glycosylation represents 50% of the molecular mass of the human immunodeficiency virus mature envelope glycoproteins (Env), The functional significance of this unusually high level of glycosylation has been partially clarified through a variety of experimental approaches and this has resulted in a demonstrable role. for glycans in posttranslational events, including efficient intracellular routing and the functional folding of the molecule. Alteration of Env glycosylation may, therefore, modulate biological activity and offers the possibility of reducing virus pathogenicity; indeed, removal of glycosylation sites or alteration of the pattern of glycosylation by drug treatment have both been shown to lead to impaired virus infectivity. As a target for antiviral therapy based on the alteration of glycosylation, therefore, HIV Env represents an attractive target.
引用
收藏
页码:203 / 212
页数:10
相关论文
共 52 条
[1]   CARBOHYDRATE DETERMINANT NEUAC-GAL-BETA(1-4) OF N-LINKED GLYCANS MODULATES THE ANTIGENIC ACTIVITY OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 GLYCOPROTEIN GP120 [J].
BOLMSTEDT, A ;
OLOFSSON, S ;
SJOGRENJANSSON, E ;
JEANSSON, S ;
SJOBLOM, I ;
AKERBLOM, L ;
HANSEN, JES ;
HU, SL .
JOURNAL OF GENERAL VIROLOGY, 1992, 73 :3099-3105
[2]   EFFECTS OF MUTATIONS IN GLYCOSYLATION SITES AND DISULFIDE BONDS ON PROCESSING, CD4-BINDING AND FUSION ACTIVITY OF HUMAN-IMMUNODEFICIENCY-VIRUS ENVELOPE GLYCOPROTEINS [J].
BOLMSTEDT, A ;
HEMMING, A ;
FLODBY, P ;
BERNTSSON, P ;
TRAVIS, B ;
LIN, JPC ;
LEDBETTER, J ;
TSU, T ;
WIGZELL, H ;
HU, SL ;
OLOFSSON, S .
JOURNAL OF GENERAL VIROLOGY, 1991, 72 :1269-1277
[3]   SEQUENCE OF SIMIAN IMMUNODEFICIENCY VIRUS FROM MACAQUE AND ITS RELATIONSHIP TO OTHER HUMAN AND SIMIAN RETROVIRUSES [J].
CHAKRABARTI, L ;
GUYADER, M ;
ALIZON, M ;
DANIEL, MD ;
DESROSIERS, RC ;
TIOLLAIS, P ;
SONIGO, P .
NATURE, 1987, 328 (6130) :543-547
[4]   DELETION OF A SINGLE N-LINKED GLYCOSYLATION SITE FROM THE TRANSMEMBRANE ENVELOPE PROTEIN OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 STOPS CLEAVAGE AND TRANSPORT OF GP160 PREVENTING ENV-MEDIATED FUSION [J].
DASH, B ;
MCINTOSH, A ;
BARRETT, W ;
DANIELS, R .
JOURNAL OF GENERAL VIROLOGY, 1994, 75 :1389-1397
[5]   ATTENUATION OF HIV-1 INFECTIVITY BY AN INHIBITOR OF OLIGOSACCHARIDE PROCESSING [J].
DEDERA, D ;
VANDERHEYDEN, N ;
RATNER, L .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1990, 6 (06) :785-794
[6]   ROLE OF ASPARAGINE-LINKED GLYCOSYLATION IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 TRANSMEMBRANE ENVELOPE FUNCTION [J].
DEDERA, DA ;
GU, RL ;
RATNER, L .
VIROLOGY, 1992, 187 (01) :377-382
[7]   MUTATION OF CONSERVED N-GLYCOSYLATION SITES AROUND THE CD4-BINDING SITE OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 GP120 AFFECTS VIRAL INFECTIVITY [J].
DIRCKX, L ;
LINDEMANN, D ;
ETTE, R ;
MANZONI, C ;
MORITZ, D ;
MOUS, J .
VIRUS RESEARCH, 1990, 18 (01) :9-20
[8]   FOLDING AND ASSEMBLY OF VIRAL MEMBRANE-PROTEINS [J].
DOMS, RW ;
LAMB, RA ;
ROSE, JK ;
HELENIUS, A .
VIROLOGY, 1993, 193 (02) :545-562
[10]   INFECTION OF COLONIC EPITHELIAL-CELL LINES BY TYPE-1 HUMAN-IMMUNODEFICIENCY-VIRUS IS ASSOCIATED WITH CELL-SURFACE EXPRESSION OF GALACTOSYLCERAMIDE, A POTENTIAL ALTERNATIVE GP120 RECEPTOR [J].
FANTINI, J ;
COOK, DG ;
NATHANSON, N ;
SPITALNIK, SL ;
GONZALEZSCARANO, F .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (07) :2700-2704